Does RISANKIZUMAB-RZAA Cause Covid-19? 2,145 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,145 reports of Covid-19 have been filed in association with RISANKIZUMAB-RZAA. This represents 3.3% of all adverse event reports for RISANKIZUMAB-RZAA.
2,145
Reports of Covid-19 with RISANKIZUMAB-RZAA
3.3%
of all RISANKIZUMAB-RZAA reports
55
Deaths
640
Hospitalizations
How Dangerous Is Covid-19 From RISANKIZUMAB-RZAA?
Of the 2,145 reports, 55 (2.6%) resulted in death, 640 (29.8%) required hospitalization, and 4 (0.2%) were considered life-threatening.
Is Covid-19 Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 2,145 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Death (1,700)
Fall (1,666)
Surgery (1,662)
Headache (1,554)
What Other Drugs Cause Covid-19?
NIRMATRELVIR\RITONAVIR (22,066)
OCRELIZUMAB (11,454)
ADALIMUMAB (9,138)
DUPILUMAB (6,986)
RITUXIMAB (6,301)
LENALIDOMIDE (6,223)
TOFACITINIB (4,926)
SECUKINUMAB (3,871)
INFLIXIMAB (3,698)
TACROLIMUS (3,201)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Covid-19 Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA